A comparison of non-HDL and LDL cholesterol goal attainment in the CHILLAS trial

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 4340-4342

  Yu, Bi Lian ^a   Zhao, Shui Ping ^a   Peng, Dao Quan ^a   Huo, Yong ^b   Hu, Lu ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Acute coronary syndrome; LDL C; Non HDL C; Statins

Indexed keywords

ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; CARDIOVASCULAR RISK; CHINA; CHOLESTEROL BLOOD LEVEL; DRUG DOSE TITRATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GOAL ATTAINMENT; HUMAN; ISCHEMIC HEART DISEASE; LETTER; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; CONTROLLED STUDY; HYPERLIPIDEMIAS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ACUTE CORONARY SYNDROME; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED;

EID: 84886287580     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.05.080     Document Type: Article

References (10)

1. S.C. Smith, J. Allen, and S.N. Blair AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute Circulation 113 2006 2363 2372
2. European Association for Cardiovascular Prevention & Rehabilitation, Z. Reiner, and A.L. Catapano ESC/EAS Guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J 32 2011 1769 1818
3. D.Y. Hu, and R.J. Ding Guidelines for management of adult dyslipidemia in China Zhonghua Nei Ke Za Zhi 47 2008 723 724
4. S.S. Virani Non-HDL cholesterol as a metric of good quality of care: opportunities and challenges Tex Heart Inst J 38 2011 160 162
5. S.S. Virani Implementation strategies to improve non-HDL-cholesterol goal attainment: current evidence and a conceptual framework for future directions Tex Heart Inst J 39 2012 228 230
6. S.P. Zhao, D.Q. Peng, and B.L. Yu Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study Am Heart J 158 2009 509 512.e1
7. M.H. Davidson, K.C. Maki, and T.A. Pearson Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations Am J Cardiol 96 2005 556 563
8. D.D. Waters, C. Brotons, and C.-W. Chiang Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals Circulation 120 2009 28 34
9. A.G. Olsson, C. Lindahl, and I. Holme LDL cholesterol goals and cardiovascular risk during statin treatment: the IDEAL study Eur J Cardiovasc Prev Rehabil 18 2011 262 269
10. C. Melloni, B.R. Shah, and F.S. Ou Lipid-lowering intensification and low-density lipoprotein cholesterol achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event: results from the Medications ApplIed aNd SusTAINed Over Time (MAINTAIN) registry Am Heart J 160 2010 1121 1129